Name | Number of supported studies | Average coverage | |
---|---|---|---|
luminal cell of prostate epithelium | 4 studies | 26% ± 6% |
Insufficient scRNA-seq data for expression of NKX3-1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 25380.15 | 245 / 245 | 100% | 1355.92 | 502 / 502 |
breast | 97% | 264.34 | 445 / 459 | 86% | 21.31 | 965 / 1118 |
adrenal gland | 100% | 498.94 | 258 / 258 | 83% | 4.95 | 191 / 230 |
uterus | 99% | 235.58 | 168 / 170 | 79% | 7.75 | 363 / 459 |
esophagus | 93% | 300.68 | 1338 / 1445 | 79% | 7.45 | 144 / 183 |
lung | 96% | 219.43 | 556 / 578 | 72% | 5.09 | 837 / 1155 |
bladder | 100% | 194.43 | 21 / 21 | 58% | 3.70 | 291 / 504 |
pancreas | 74% | 79.12 | 242 / 328 | 71% | 3.61 | 127 / 178 |
ovary | 100% | 270.29 | 180 / 180 | 42% | 2.18 | 181 / 430 |
stomach | 91% | 147.61 | 328 / 359 | 39% | 1.86 | 111 / 286 |
liver | 98% | 188.13 | 222 / 226 | 29% | 1.13 | 118 / 406 |
brain | 80% | 94.86 | 2111 / 2642 | 41% | 1.47 | 292 / 705 |
kidney | 85% | 106.99 | 76 / 89 | 35% | 1.27 | 315 / 901 |
intestine | 87% | 167.08 | 842 / 966 | 32% | 1.82 | 167 / 527 |
thymus | 82% | 74.03 | 534 / 653 | 26% | 1.23 | 160 / 605 |
skin | 69% | 97.59 | 1242 / 1809 | 36% | 2.57 | 170 / 472 |
muscle | 100% | 296.20 | 803 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 221.69 | 830 / 861 | 0% | 0 | 0 / 0 |
spleen | 93% | 93.66 | 224 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 9.04 | 40 / 45 |
adipose | 87% | 164.55 | 1051 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 78% | 92.26 | 1043 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 45% | 1.75 | 13 / 29 |
peripheral blood | 40% | 42.85 | 372 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 31% | 1.28 | 25 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0060037 | Biological process | pharyngeal system development |
GO_0033574 | Biological process | response to testosterone |
GO_0060442 | Biological process | branching involved in prostate gland morphogenesis |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0051781 | Biological process | positive regulation of cell division |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0007431 | Biological process | salivary gland development |
GO_0060664 | Biological process | epithelial cell proliferation involved in salivary gland morphogenesis |
GO_0048754 | Biological process | branching morphogenesis of an epithelial tube |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0007507 | Biological process | heart development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0001656 | Biological process | metanephros development |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0006974 | Biological process | DNA damage response |
GO_0032880 | Biological process | regulation of protein localization |
GO_0071383 | Biological process | cellular response to steroid hormone stimulus |
GO_2001244 | Biological process | positive regulation of intrinsic apoptotic signaling pathway |
GO_2000836 | Biological process | positive regulation of androgen secretion |
GO_0035907 | Biological process | dorsal aorta development |
GO_0071347 | Biological process | cellular response to interleukin-1 |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0060770 | Biological process | negative regulation of epithelial cell proliferation involved in prostate gland development |
GO_0045931 | Biological process | positive regulation of mitotic cell cycle |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030154 | Biological process | cell differentiation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0001756 | Biological process | somitogenesis |
GO_0060767 | Biological process | epithelial cell proliferation involved in prostate gland development |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0043569 | Biological process | negative regulation of insulin-like growth factor receptor signaling pathway |
GO_0008584 | Biological process | male gonad development |
GO_0006915 | Biological process | apoptotic process |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_2001235 | Biological process | positive regulation of apoptotic signaling pathway |
GO_0030521 | Biological process | androgen receptor signaling pathway |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090734 | Cellular component | site of DNA damage |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_0008656 | Molecular function | cysteine-type endopeptidase activator activity involved in apoptotic process |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0140416 | Molecular function | transcription regulator inhibitor activity |
GO_0030331 | Molecular function | nuclear estrogen receptor binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0097162 | Molecular function | MADS box domain binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | NKX3-1 |
Protein name | Homeobox protein Nkx-3.1 (Homeobox protein NK-3 homolog A) |
Synonyms | NKX3A NKX3.1 |
Description | FUNCTION: Transcription factor, which binds preferentially the consensus sequence 5'-TAAGT[AG]-3' and can behave as a transcriptional repressor. Plays an important role in normal prostate development, regulating proliferation of glandular epithelium and in the formation of ducts in prostate. Acts as a tumor suppressor controlling prostate carcinogenesis, as shown by the ability to inhibit proliferation and invasion activities of PC-3 prostate cancer cells. . |
Accessions | Q99801 ENST00000380871.5 [Q99801-1] ENST00000523261.1 [Q99801-3] |